Holen Sie sich die Stockscreener-App
16.16
0.32%
-0.10
Schlusskurs vom Vortag:
$16.26
Offen:
$16.1
24-Stunden-Volumen:
57,748
Relative Volume:
0.07
Marktkapitalisierung:
$1.26B
Einnahmen:
$1.64B
Nettoeinkommen (Verlust:
$-495.80M
KGV:
-2.5234
EPS:
-6.404
Netto-Cashflow:
$-45.25M
1W Leistung:
-3.58%
1M Leistung:
-6.04%
6M Leistung:
+69.37%
1J Leistung:
+5.05%
1-Tages-Spanne:
$15.99
$16.46
1-Wochen-Bereich:
$15.98
$17.11
52-Wochen-Spanne:
$8.70
$20.49
Integra Lifesciences Holdings Corp Stock (IART) Company Profile
Firmenname
Integra Lifesciences Holdings Corp
Sektor
Branche
Telefon
(609) 275-0500
Adresse
1100 CAMPUS ROAD, PRINCETON, NJ
Compare IART vs ABT, MDT, SYK, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IART
Integra Lifesciences Holdings Corp
|
16.16 | 1.26B | 1.64B | -495.80M | -45.25M | -6.404 |
ABT
Abbott Laboratories
|
106.02 | 182.59B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
92.81 | 118.18B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
273.46 | 106.03B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
45.59 | 65.19B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.44 | 49.99B | 6.30B | 1.07B | 1.09B | 1.8406 |
Integra Lifesciences Holdings Corp Stock (IART) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-15 | Herabstufung | Argus | Buy → Hold |
| 2025-03-31 | Hochstufung | Argus | Hold → Buy |
| 2024-12-02 | Eingeleitet | Morgan Stanley | Underweight |
| 2024-10-07 | Hochstufung | BTIG Research | Sell → Neutral |
| 2024-07-30 | Herabstufung | BTIG Research | Neutral → Sell |
| 2024-07-30 | Herabstufung | Citigroup | Neutral → Sell |
| 2024-05-07 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2024-05-07 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-04-03 | Hochstufung | Citigroup | Sell → Neutral |
| 2023-12-05 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-11-14 | Eingeleitet | CL King | Buy |
| 2023-08-24 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2023-07-12 | Hochstufung | Jefferies | Hold → Buy |
| 2023-06-08 | Herabstufung | Argus | Buy → Hold |
| 2023-05-24 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2023-05-23 | Herabstufung | Citigroup | Neutral → Sell |
| 2022-10-12 | Eingeleitet | Jefferies | Hold |
| 2022-07-25 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-04-13 | Herabstufung | Truist | Buy → Hold |
| 2021-12-17 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2021-09-15 | Herabstufung | BTIG Research | Buy → Neutral |
| 2020-10-08 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2020-05-27 | Eingeleitet | Citigroup | Neutral |
| 2020-04-03 | Eingeleitet | SunTrust | Buy |
| 2020-01-07 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2020-01-07 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2019-01-03 | Eingeleitet | SunTrust | Buy |
| 2018-11-28 | Eingeleitet | UBS | Neutral |
| 2018-08-07 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2018-07-26 | Hochstufung | BTIG Research | Neutral → Buy |
| 2018-07-02 | Herabstufung | Citigroup | Buy → Neutral |
| 2018-01-05 | Fortgesetzt | Cantor Fitzgerald | Neutral |
| 2018-01-02 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2017-11-09 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2017-10-30 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2017-10-27 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2017-06-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2017-05-02 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2017-01-13 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2017-01-06 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2016-12-12 | Eingeleitet | UBS | Buy |
Alle ansehen
Integra Lifesciences Holdings Corp Aktie (IART) Neueste Nachrichten
Integra LifeSciences on Track to Complete FDA Remediation in 2026 - Minichart
Integra executives will speak at two healthcare conferences - Stock Titan
Integra LifeSciences: Strong Q2 2026 Results Support Recovery Thesis (NASDAQ:IART) - Seeking Alpha
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds Integra LifeSciences (IART) Investors of Pending Securities Fraud Class Action, Encourages Investors with Substantial Losses to Contact Firm's Attorneys - TMX Newsfile
Is IART Still Attractive as Its Low Valuation Meets Execution Risks? - TradingView
Assenagon Asset Management S.A. Reduces Position in Integra LifeSciences Holdings Corporation $IART - MarketBeat
Integra LifeSciences /US Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Paradigm Capital discloses 4.42% Integra LifeSciences (IART) stake with sole voting control - Stock Titan
Integra LifeSciences (NASDAQ:IART) Stock Price Up 6.6%Time to Buy? - MarketBeat
Quantinno Capital Management LP Reduces Holdings in Integra LifeSciences Holdings Corporation $IART - MarketBeat
Integra LifeSciences Holdings Corporation (IART) Interactive Stock Chart - Yahoo! Finance Canada
5 Must-Read Analyst Questions From Integra LifeSciences’s Q2 Earnings Call - Yahoo Finance
Integra LifeSciences Holdings Corporation $IART Stock Position Trimmed by Dimensional Fund Advisors LP - MarketBeat
IART 10-DAY DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages Integra LifeSciences (IART) Investors with Substantial Losses to Contact the Firm Before Nov. 13th Deadline in Securities Fraud Class Action - TMX Newsfile
Glenmede Trust Co. NA Raises Stock Holdings in Integra LifeSciences Holdings Corporation $IART - MarketBeat
Healthcare of Ontario Pension Plan Trust Fund Sells 96,400 Shares of Integra LifeSciences Holdings Corporation $IART - MarketBeat
List of 16 Acquisitions by Integra LifeSciences (Aug 2026) - Tracxn
integra lifesciences holdings corp Profit Warnings - RTTNews
Access Investment Management LLC Buys 268,085 Shares of Integra LifeSciences Holdings Corporation $IART - MarketBeat
Vanguard Portfolio Management (IART) discloses 3.9M-share position in Integra - Stock Titan
Zacks.com featured highlights include Bassett Furniture, Aveanna Healthcare and Integra LifeSciences - The Globe and Mail
IART|Integra Lifesciences Holdings Corp|Price:18.245|Chg%:+0.005 - tradingkey.com
Integra Lifesciences Holdings Corp reports results for the quarter ended June 30Earnings Summary - TradingView
Is Integra Lifesciences Holdings Corp (IART) Undervalued After Q - GuruFocus
Integra: Q2 Earnings Snapshot - kare11.com
Integra LifeSciences Reports Second Quarter 2026 Results, Updates Full-Year Revenue Guidance and Reaffirms EPS Outlook - Quiver Quantitative
Integra LifeSciences Reports Second Quarter 2026 Financial Results - Yahoo Finance Singapore
Integra starts production for planned fourth-quarter SurgiMend relaunch - Stock Titan
Integra LifeSciences earnings up next: Can turnaround hold? - Investing.com
UBS initiates Integra LifeSciences stock with neutral rating - Investing.com
Ultrasonic Aspirator Market Size Projected to Reach USD 376.32 Million by 2035 | SNS Insider - GlobeNewswire Inc.
Integra LifeSciences (IART) To Report Earnings Tomorrow: Here Is What To Expect - Yahoo Finance
Integra Lifesciences Holdings Corp (IART) Institutional Confidence - TradingKey
Integra Lifesciences Holdings Corp (IART) Shareholder Structure: Major Shareholders & Institutional Holdings - tradingkey.com
Integra Lifesciences Holdings Corp (IART) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Integra Lifesciences Holdings Corp - TradingKey
Integra LifeSciences (NASDAQ:IART) Reaches New 12-Month HighShould You Buy? - MarketBeat
IART|Integra Lifesciences Holdings Corp|Price:19.530|Chg%:-0.260 - TradingKey
Integra Lifesciences Holdings Corp (IART) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
TradingKey - TradingKey
Integra Lifesciences Holdings Corp (IART) Cash Flow - TradingKey
Paradigm Capital Management Inc. NY Boosts Position in Integra LifeSciences Holdings Corporation $IART - MarketBeat
Integra LifeSciences Holdings Corporation (IART) Stock Price, News, Quote & History - Yahoo! Finance Canada
Integra LifeSciences (NASDAQ:IART) Stock Price Up 6.4%Still a Buy? - MarketBeat
Kaskela Law Firm Announces Investigation of Integra LifeSciences - GuruFocus
Kaskela Law investigates Integra LifeSciences over alleged cGMP violations - scanx.trade
Integra LifeSciences (IART) to Announce Earnings on Wednesday - MarketBeat
Integra LifeSciences (NASDAQ:IART) Downgraded by Wall Street Zen to Buy - MarketBeat
How Integra LifeSciences’ Earnings Outperformance Track Record At Integra LifeSciences Holdings (IART) Has Changed Its Investment Story - Yahoo Finance
A Look at Integra Lifesciences Holdings Corp (IART) After 3.1% D - GuruFocus
Integra LifeSciences Holdings (IART) Stock Still Looks Below Fair Value Following A 70% Five Year Fall - Yahoo Finance
Finanzdaten der Integra Lifesciences Holdings Corp-Aktie (IART)
Umsatz
Nettogewinn
Free Cashflow
ENV
Integra Lifesciences Holdings Corp-Aktie (IART) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Singh Harvinder | EVP & PRESIDENT, INTERNATIONAL |
Mar 10 '26 |
Option Exercise |
0.00 |
1,216 |
0 |
23,152 |
| Poul Mojdeh | President & CEO |
Jan 06 '26 |
Option Exercise |
0.00 |
1,390 |
0 |
1,390 |
| GRAVES JEFFREY A | Director |
Nov 05 '25 |
Buy |
11.35 |
9,000 |
102,150 |
41,086 |
| Singh Harvinder | EVP & PRESIDENT, INTERNATIONAL |
Oct 12 '25 |
Option Exercise |
0.00 |
11,965 |
0 |
25,217 |
0.72%
0.63%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):